Sign in

AXA SA CS.PA

Price 44.6 EUR
as of 2026-09-05
55/100
Constructive
Quality45
Growth51
Balance-sheet strength41
Valuation63
Momentum73
Income89

Composite 55/100; the shares have moved about 17% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.

Strongest counter-signal

Balance-sheet strength ranks 41/100 — a slight mark against it.

Case for

Income ranks 89/100 — a strong point in its favour. Momentum ranks 73/100 — a moderate point in its favour. Valuation ranks 63/100 — a moderate point in its favour.

Case against

Balance-sheet strength ranks 41/100 — a slight mark against it. Quality ranks 45/100 — a slight mark against it.

What the company does AXA SA is a diversified global insurer offering life, savings, property-casualty, reinsurance, asset management, and health services across France, Europe, Asia, and the Americas.

Key financials ROE 13%, ROA 1%, ROCE 14%; gross/operating/net margins 15%/11%/10%. Revenue grew 3%, EPS up 60%. Debt/equity 1.14, interest coverage 17x, current ratio 1.93. Dividend yield 5%, payout 63%.

Stock health Sideravia scores: Quality 47, Growth 65, Strength 40, Valuation 81, Momentum 77, Income 93. Piotroski 6/9, Altman Z –0.27. RSI 65; 12m return 21%.

Price vs fair value The stock trades at a DISCOUNT of 31% to our fair-value estimate of 59 and a DISCOUNT of 9% to the 12-month target of 49. - AXA reaffirmed 2026 targets after first-half earnings beat (WSJ 2026-07-31) - Deutsche Bank traders see revenue jump ahead of expectations (Bloomberg 2026-07-29) - Valuation percentile 81/100 and forward P/E 11x vs sector median (analyst data)

Looking forward Forward P/E 11x and PEG 0.5x imply undemanding multiples. Analysts cite improving underwriting and asset management as key drivers.

sideravia.comEvery stock argues both sides.
Research, not advice · sideravia.com/conflicts — read the policy

This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.

Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.